Skip to main content
. Author manuscript; available in PMC: 2022 Aug 29.
Published in final edited form as: Nat Med. 2020 Aug 31;26(11):1776–1787. doi: 10.1038/s41591-020-1039-5

Extended Data Fig. 4 |. Dual-CAR T cell product transiently delays CD4+ T cell loss despite persistent HIVJRCSF infection.

Extended Data Fig. 4 |

BLT mice received Dual-CAR T cell product (TCP) (n = 6) 48 h after HIVJRCSF challenge, while control mice were untreated (Untx) (n = 5). a, Concentration of peripheral total memory CD4+ T cells (CAR). b, Concentration of peripheral central memory (CD45RA−CD27+CCR7+; left panel), transitional memory (CD45RACD27+CCR7; middle panel), and effector memory (CD45RACD27CCR7; right panel) CD4+ T cells (CAR). c, Frequency of memory CD4+ T cell (CAR) subsets in tissues 8 weeks post-infection. a, b, Significance was calculated using a two-sided Wilcoxon rank-sum test. Symbols and bars indicate mean, and error bars show ± SEM. Sample sizes indicate biologically independent animals.